Nextcure Rg

Clinical‑stage biotech focused on solid tumor immunotherapies, developing B7‑H4 ADC LNCB74, LAIR‑2 fusion NC410, and antibodies NC525 (AML), NC181 (Alzheimer's), NC605 (osteoarthritis). Headquartered in Beltsville, MD.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 43
HQ: Beltsville

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
NXTC	Nextcure Rg Cap: 0.0B	EQUITY	NMS	USD	US65343E1082	Active	📈